Posted on 2/26/18
Blue Cross Blue Shield of Massachusetts Announces Major Expansion Of National Dental Network
Access to dental services continues to be an issue for many Americans, with the American Dental Association reporting that 1 in 3 Americans face challenges finding . . .
Posted on 2/26/18
PAREXEL Receives Two Industry Recognitions for its Diverse and Flexible Workplace
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced that the Company has been recognized for its diverse and flexible workplace by . . .
Posted on 2/26/18
Berkshire Hathaway Earnings Soar Thanks to the Corporate Tax Cut
Berkshire Hathaway's (NYSE:BRK-A)(NYSE:BRK-B) earnings soared in 2017, but even Warren Buffett admits that most of the earnings jump wasn't his doing. Shareholders should instead thank the . . .
Posted on 2/26/18
Teva: Berkshire Thinks Bondholders Are 'Mullet Mullet'
Warren Buffett of Berkshire Hathaway. Source: medium.comTeva (TEVA) has been reeling since Mylan's (MYL) generic Copaxone was approved Q4 2017. Having one's most-profitable drug go generic . . .
Posted on 2/23/18
Would Pfizer Investors Win With a Bristol-Myers Squibb Acquisition?
You can almost hear the sound of keyboards at Pfizer's (NYSE:PFE) headquarters in New York crunching the numbers on potential deals. The giant drugmaker was eerily . . .
Posted on 2/23/18
Berkshire Hathaway Earnings Preview: 5 Things to Watch
On Feb. 24, Warren Buffett's Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) will report earnings for the fourth quarter of 2017, and release Buffett's widely read letter to shareholders describing . . .
Posted on 2/21/18
Professional Physical Therapy Welcomes Ramsey Rehab in Central Massachusetts
The Country’s Top Physical Therapy Practice Now Serves Six New Communities in New England Professional Physical Therapy, a leading private, outpatient physical therapy provider in the . . .
Posted on 2/21/18
6 Reasons Buffett Bought Into Teva Pharmaceutical, as Told by a Teva Shareholder
The past couple of years have been rough on Teva Pharmaceutical Industries (NYSE:TEVA)and its shareholders. The largest maker of generic drugs and developer of a handful . . .
Posted on 2/21/18
Bristol-Myers Squibb: Next Stop, Record Levels
Bristol-Myers Squibb (BMY) is breaking out higher on strong momentum as its blockbuster drugs are experiencing global commercial success. After months of consolidation, BMY's share price . . .
Posted on 2/21/18
Can Bristol-Myers Squibb Squeeze $3.6 Billion From Its Nektar Therapeutics Deal?
Bristol-Myers Squibb Co. (NYSE:BMY) recently signed a huge deal with Nektar Therapeutics(NASDAQ:NKTR) to secure a minority stake in an experimental drug that produced some interesting data . . .
Posted on 2/21/18
AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration
AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company, today announced that they have entered into an . . .
Posted on 2/21/18
Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia
Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders today announced the separation and spin-off of its . . .
Posted on 2/21/18
Fast Company Recognizes CVS Health on 2018 World's Most Innovative Companies List
CVS Health (NYSE: CVS), the nation's largest pharmacy innovation company, was recognized today by Fast Company as one of the World's 50 Most Innovative Companies List . . .
Posted on 2/21/18
Spring Bank Pharmaceuticals Provides Corporate Update
HOPKINTON, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, . . .
Posted on 2/21/18
Tetraphase Pharmaceuticals Enters into Development and Commercialization Agreement with Everest Medicines for Eravacycline in China
WATERTOWN, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) . . .
Posted on 2/20/18
Clarity Named One of the Best Places to Work in Connecticut
Madison, CT, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Clarity Software Solutions, Inc. was recently named as one of the Best Places to Work in Connecticut. This . . .
Posted on 2/20/18
Casa Systems Participates in Remote PHY Interoperability Event at CableLabs
ANDOVER, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Casa Systems, a leading provider of end-to-end network infrastructure technology solutions for wireline and wireless networks today announced . . .
Posted on 2/20/18
Cedars-Sinai and Emulate Advance Precision Medicine With Organs-on-Chips, Stem Cells
Scientists at Cedars-Sinai and Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic . . .
Posted on 2/20/18
BSX: Boston Scientific Corporation SEC Filing - Annual Report (10-K) February 20, 2018
Our CompanyBoston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our . . .
Posted on 2/20/18
Teva: Berkshire Is Barking Up The Wrong Tree
Warren Buffett of Berkshire Hathaway. Source: medium.comTeva (TEVA) reported more disappointing results for Q4. Revenue and EBITDA fell Y/Y by 16% and 29%, respectively. Somehow Berkshire . . .
Posted on 2/20/18
How Celgene Hopes to Cash In on CAR-T
Chimeric antigen T-cell therapy (CAR-T) is an important new approach to battling blood cancer, and while it's too soon to say what company will develop an . . .
Posted on 2/20/18
Why in the World Does Warren Buffett Like Teva Pharmaceutical?
Say it ain't so, Warren.Warren Buffett's Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) filed an update of its investment holdings to the U.S. Securities and Exchange Commission (SEC) on . . .
Posted on 2/20/18
Dicerna Pharmaceuticals: Institutional Buying Heats Up
Dicerna Pharmaceuticals (NASDAQ:DRNA) latest corporate presentation: 117READ FULL ARTICLE HERE
Posted on 2/16/18
athenahealth (ATHN) FY2018 Guidance Call - Slideshow
The following slide deck was published by athenahealth, Inc. in conjunction with this event. 1128READ FULL ARTICLE HERE
Posted on 2/15/18
Here's Why Pieris Pharmaceuticals Inc. Is Tanking
What happenedAfter the company revealed the pricing details of its recently announced common stock offering, shares of Pieris Pharmaceuticals (NASDAQ:PIRS), a clinical-stage biotech focused on cancer . . .

